Avenzo Deal History & Licensing Activity
Avenzo is a life sciences. Over the past three years, Avenzo has been involved in 3 licensing and acquisition transactions, with a primary focus on Other (4 deals). The company currently has 4 active clinical trials, primarily in Mega Deals.
Deals (12mo)
0
Active Trials
4
Top Modality
Other
Focus Area
Mega Deals
Avenzo Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Avenzo in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| rare disease program | Rallybio | Other | Unknown | collaboration | Jun 3, 2026 |
| rare disease program | Rallybio | Other | Unknown | collaboration | Jun 1, 2026 |
Avenzo Pipeline Focus
Therapeutic areas and modalities where Avenzo is most active based on deal history and clinical trial data.
Therapeutic Areas
Avenzo Strategic Signals
Key indicators of Avenzo's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Avenzo Clinical Pipeline
Avenzo has 4 active clinical trials across 1 development phase.
4
Phase 1
See How Your Asset Matches Avenzo's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Mega Deals assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Women's Health Deal Benchmarks
Market sizing, deal terms, and competitive landscape for women's health
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
ADC Benchmarks
Upfront, milestone, and royalty benchmarks for adc deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
About Avenzo Licensing & Deal Activity
Avenzo is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 3 deals over the past three years, Avenzo ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Avenzo include Mega Deals (4 deals and trials), Solid Tumors (4 deals and trials), and Women's Health (1 deal and trial). In terms of modality, Avenzo has shown particular interest in other, adc.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Avenzo and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Avenzo's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.